Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Juntendo Co., Ltd. (9835:JPX), powered by AI.
Juntendo Co., Ltd. is currently trading at ¥508. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Juntendo Co., Ltd. on Alpha Lenz.
View Juntendo Co., Ltd.'s valuation metrics on Alpha Lenz.
“Juntendo Co., Ltd.'s ROE is 1.2%. Explore profitability and growth together.”
Ask for details →Juntendo Co., Ltd. is a prominent company based in Japan that specializes in the wholesale distribution of pharmaceuticals, medical supplies, and healthcare-related products. The primary function of Juntendo is to serve as a crucial intermediary between manufacturers of healthcare products and the various institutions that require them, such as hospitals, clinics, and pharmacies. With a focus on the healthcare sector, Juntendo plays a vital role in ensuring that medical and pharmaceutical products are efficiently distributed across Japan, contributing to the country's healthcare infrastructure. Juntendo is known for its comprehensive distribution network and ability to manage logistics efficiently, which includes the storage, transportation, and timely delivery of medical supplies. This capability is essential given the sensitive nature and regulatory requirements of the pharmaceutical industry. Juntendo's impact is significant within the healthcare supply chain, as it supports the medical industry's demand for reliable and prompt delivery services. The company's operations are integral to maintaining public health standards and facilitating access to necessary medical supplies and pharmaceuticals in Japan's healthcare market.
“Juntendo Co., Ltd.'s ROE is 1.2%. Explore profitability and growth together.”
Ask for details →Juntendo Co., Ltd. (ticker: 9835) is a company listed on JPX in the Consumer Cyclical sector (Home Improvement Retail). It has approximately 673 employees.
The current price is 508 with a P/E ratio of -x and P/B of -x.
ROE is 1.19% and operating margin is 1.07%. Annual revenue is $44.4B.